A2: Yes, one of the unique properties of BPC-157 Peptide Therapy is its strong protective effect on the gastrointestinal lining
This study explores a novel metabolism-based therapeutic approach using a polyurea generation 4 dendrimer (PURE G4 ) surface functionalized with lactate (LA) (PURE G4 -LA 24 ), to take advantage of glucose-dependent monocarboxylate transporters (MCTs) overexpression, loaded with selenium-chrysin (SeChry) and temozolomide (TMZ) or complexed with anti-glutaminase ( GLS1 ) siRNAs to abrogate glutamine dependence

Key Ingredients Water, Centella Asiatica Extract (12.3%), Glycerin, Cetyl Ethylhexanoate, Cetearyl Alcohol, Glyceryl Stearate, Glutathione (1,000ppm), Niacinamide (1,000ppm), Madecassic Acid, Asiaticoside, Asiatic Acid, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Squalane, Sodium Hyaluronate, Dipropylene Glycol, Butylene Glycol, Hydrogenated Lecithin, Cholesterol, Xanthan Gum, Potassium Hydroxide, Disodium EDTA, Caprylic/Capric Triglyceride, Cyclopentasiloxane, Cyclohexasiloxane, Saccharide Hydrolysate, Sorbitan Stearate, Dimethicone, PEG-100 Stearate, Stearic Acid, 1,2-Hexanediol, Chlorphenesin, Carbomer, Caprylyl Glycol
UK-wide licensing for human medicines
View All Practices Not Sure What You Need Or Where To Start